Disparities in Cardio-Oncology Strategically Focused Research Network

Grant Name
Disparities in Cardio-Oncology Strategically Focused Research Network
Funder
American Heart Association (AHA)
Country or Region
United States
Research Field
Cancer Prevention
Cardiology
Cardiovascular Disease
Health Disparities
Health of Underserved Populations
Oncology
Deadline
February 9, 2022 (Expired)
Grant Size
Upper $2,925,000USD Duration: 4 years with opportunity for up to 12-months No-Cost Extension (NCE). Number of Awards: AHA anticipates awarding four (4) Center grants* to establish the Disparities in CardioOncology SFRN. Awardees will be selected based on scientific merit and how each group aligns with AHA’s mission and goals. *The AHA reserves the right to determine the final number of awardees. Award Amount: The maximum budget amount a Center applicant may request is $2,925,000. The AHA reserves the right to determine the final award amount for competitive projects based on need and potential impact.
Contact Info
SFRN@heart.org
Eligibility
Applicants to AHA SFRN award mechanisms, the Center Director and each project PI must be an AHA Member/Partner. AHA SFRN awards are limited to U.S.-based non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research.
Description
Cardio-oncology represents the intersection of cancer and cardiovascular disease. It has emerged as a new research area as a result of the evolution in cancer therapies which have improved prognosis for many cancer patients. Cardiovascular complications from cancer therapies represent an important challenge for many cancer patients, both at the time of treatment as well as during survivorship. To address critical deficiencies related to disparities in cardio-oncology, AHA has prioritized funding research that increases the understanding of the etiology, pathophysiology, treatment and prevention of cardiovascular disease among cancer patients and cancer survivors from diverse populations. Cancer patients and/or survivors are often not included in cardiovascular studies. Understanding mechanistic underpinnings of cardiac complications, especially targeted and immune-based therapies, can lead to better diagnostic, preventive and treatment strategies. Furthermore, data describing differences in cardiovascular toxicities associated with cancer therapies are sparse. This SFRN provides the AHA with a mechanism to advance the understanding of the causes, pathophysiology, risk factors, epidemiology, prevention and treatment of cardiovascular disease in those patients who are currently undergoing or have undergone cancer treatment (or applicable models). Applicants are requested to focus in particular on areas that have not been previously explored in cardiooncology, and must include diverse and/or underrepresented cohorts in proposed studies. The intent of this initiative is to support a collaboration of basic, clinical and population (or implementation) researchers whose collective efforts will lead to new approaches to the study of cardiooncology. Each Center must propose two (2) or three (3) projects representing at least two of the following research disciplines: basic, clinical, and population science. All projects must focus on disparities in cardiooncology. Population studies are inclusive of projects ranging from cohort studies to translational or implementation research involving community interventions. All projects must address health and health care disparities and/or health equity in the cardio-oncology domain. Eligibility Applicants to AHA SFRN award mechanisms, the Center Director and each project PI must be an AHA Member/Partner. AHA SFRN awards are limited to U.S.-based non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research.

Funding resources

2023 AHA Research Funding Application Instructions Download File
AHA Research Funding Process Infographic Download File
Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

February 9, 2022

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Related opportunities

International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
European Partnership: One Health Anti-Microbial Resistance
Antimicrobial resistance 2024-09-25 €100000000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Strategic Prevention Framework – Partnerships for Success for States
Health Jun 05, 2025 12:00:00 AM EDT $1,250,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $400,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): MOMENTUM Monitoring and evaluation, knowledge management and translation
Medicine September 30, 2025 Up to 25,000,000 USD
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 200,000,000 USD